STOCK TITAN

TOVX ownership update: 739,211 shares disclosed on Schedule 13G

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Theriva Biologics (TOVX) reported a new Schedule 13G indicating that the Jeffrey Matthew Gryga Irrevocable Trust beneficially owns 739,211 shares of common stock, representing 7.7% of the class as of the event date 10/24/2025.

The trust has sole voting and dispositive power over these 739,211 shares. Jeffrey Matthew Gryga, as sole trustee, reports shared voting and dispositive power over the same shares through the trust. The filing includes a certification that the securities were not acquired for the purpose of changing or influencing control of the issuer.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G




Comment for Type of Reporting Person: Jeffrey Matthew Gryga is the sole Trustee of the Jeffrey Matthew Gryga Irrevocable Trust.


SCHEDULE 13G



Jeffrey Matthew Gryga Irrevocable Trust
Signature:Jeffrey Matthew Gryga
Name/Title:Jeffrey Matthew Gryga, Trustee of Jeffrey Matthew Gryga Irrevocable Trust
Date:11/10/2025
Gryga Jeffrey Matthew
Signature:Jeffrey Matthew Gryga
Name/Title:Jeffrey Matthew Gryga
Date:11/10/2025
Exhibit Information

Exhibit 99.1 - Joint Filing Agreement

FAQ

What did the Schedule 13G disclose for TOVX?

The Jeffrey Matthew Gryga Irrevocable Trust reported beneficial ownership of 739,211 TOVX common shares, equal to 7.7% of the class.

Who filed the Schedule 13G related to TOVX?

Jeffrey Matthew Gryga Irrevocable Trust and Jeffrey Matthew Gryga (sole trustee) filed jointly.

What voting and dispositive powers were reported?

The trust has sole voting and dispositive power over 739,211 shares; Jeffrey Matthew Gryga reports shared power over the same shares as trustee.

What is the reported percentage ownership of TOVX?

The filing states a 7.7% beneficial ownership of the common stock class.

What is the event date for this ownership report?

The date of the event requiring the filing is 10/24/2025.

Did the filer indicate an intent to influence control of TOVX?

No. The certification states the securities were not acquired for the purpose of changing or influencing control.

Is this filing made as part of a group?

The filing does not identify a group and is presented by the trust and trustee together under a joint filing agreement.

THERIVA BIOLOGICS INC

NYSE:TOVX

View TOVX Stock Overview

TOVX Rankings

TOVX Latest News

TOVX Latest SEC Filings

TOVX Stock Data

6.35M
34.95M
Biotechnology
Pharmaceutical Preparations
Link
United States
ROCKVILLE